Overview

NSABP Biospecimen Discovery Project

Status:
Active, not recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
This study is a biospecimen discovery project that will serve as a pilot for a comprehensive 'omics approach using fresh core biopsy tissue and blood samples for DNA and protein analysis, as well as paired tumor-normal exome DNA and RNA sequencing.
Details
Lead Sponsor:
NSABP Foundation Inc
Collaborators:
Breast Cancer Research Foundation
Washington University School of Medicine
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel
Pertuzumab
Trastuzumab